Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 10:39 PM
Study NCT ID:
NCT00405067
Status:
COMPLETED
Last Update Posted:
2014-03-04
First Post:
2006-11-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia
Sponsor:
Aegerion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2007-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-28
First Submit QC Date:
None
Study First Post Date:
2006-11-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-01-18
Results First Submit QC Date:
None
Results First Post Date:
2014-03-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-01-15
Last Update Post Date:
2014-03-04
Last Update Post Date Type:
ESTIMATED